ECPI PHARMACOLOGY EXAM 1 QUIZZES WITH
100% CORRECT ANSWERS 2025
For assistance with your assignment email me:
receptor subtype located in all autonomic nervous system ganglia and in the adrenal medulla ANS -
NicotinicN
receptor that stimulates parasympathetic and sympathetic postganglionic nerves and releases epinephr
ine form the adrenal medulla ANS - NicotinicN
receptor subtype located in the neuromuscular junction ANS - NicotinicM
receptor that causes contraction of skeletal muscle ANS - NicotinicM
receptor subtype that targets parasympathetic organs ANS - Muscarinic
receptor subtype that is located in the eye, heart, lungs, bladder, GI Tract, sweat glands, sex organs, an
d blood vessels ANS - Muscarinic
when activated, this receptor subtype causes coordinated contraction of detrusor and relaxation of the
trigone and sphincter which causes voiding of the bladder ANS - Muscarinic
receptor subtype that causes vasodilation of the blood vessels ANS - Muscarinic
receptor that causes constriction of bronchi ANS - Muscarinic
NicotinicN, NicotinicM, and Muscarinic are all receptor subtypes ANS - cholinergic
decreased pupil diameter ANS - miosis
increased pupil size ANS - mydriasis
, receptor subtype that causes mydriasis, arteriole constriction in the skin, viscera, and mucous membran
es, ejaculation, contraction of the prostatic capsule, and contraction of the trigone and bladder sphinct
er ANS - Alpha1
receptor subtype leads to Inhibition of transmitter release in presynaptic nerve terminals ANS - Alpha2
receptor subtype that leads to increased HR, force of contraction, speed of AV conduction, and causes t
he release of renin in the kidneys ANS - Beta1
receptor subtype that causes dilation of arterioles in the heart, lungs, and skeletal muscles, bronchial di
lation, uterine relaxation, glycogenolysis, and enhanced contraction of skeletal muscles ANS - Beta2
receptor subtype that effects the kidney by dilating its vasculature ANS - Dopamine
alpha1, alpha2, beta1, beta2, and dopamine are all receptor subtypes ANS - adrenergic
medication used to treat non-obstructive urinary retention ANS - Bethanechol
medication that's investigational use is to treat gastroesophageal reflux ANS - Bethanechol
medication shouldn't be used with someone who has latent or active asthma, because it causes bronchi
al constriction ANS - Bethanechol
med that should be taken without food (to avoid nausea/vomiting), so administered 1 hour before mea
ls or 2 hours after meals ANS - Bethanechol
Pilocarpine acts by lowering intraocular pressure in the eyes which treats ANS - Glaucoma
a condition that causes DIFFICULTY SWALLOWING, ptosis, fatigue, and muscle weakmess ANS -
Myasthenia gravis
100% CORRECT ANSWERS 2025
For assistance with your assignment email me:
receptor subtype located in all autonomic nervous system ganglia and in the adrenal medulla ANS -
NicotinicN
receptor that stimulates parasympathetic and sympathetic postganglionic nerves and releases epinephr
ine form the adrenal medulla ANS - NicotinicN
receptor subtype located in the neuromuscular junction ANS - NicotinicM
receptor that causes contraction of skeletal muscle ANS - NicotinicM
receptor subtype that targets parasympathetic organs ANS - Muscarinic
receptor subtype that is located in the eye, heart, lungs, bladder, GI Tract, sweat glands, sex organs, an
d blood vessels ANS - Muscarinic
when activated, this receptor subtype causes coordinated contraction of detrusor and relaxation of the
trigone and sphincter which causes voiding of the bladder ANS - Muscarinic
receptor subtype that causes vasodilation of the blood vessels ANS - Muscarinic
receptor that causes constriction of bronchi ANS - Muscarinic
NicotinicN, NicotinicM, and Muscarinic are all receptor subtypes ANS - cholinergic
decreased pupil diameter ANS - miosis
increased pupil size ANS - mydriasis
, receptor subtype that causes mydriasis, arteriole constriction in the skin, viscera, and mucous membran
es, ejaculation, contraction of the prostatic capsule, and contraction of the trigone and bladder sphinct
er ANS - Alpha1
receptor subtype leads to Inhibition of transmitter release in presynaptic nerve terminals ANS - Alpha2
receptor subtype that leads to increased HR, force of contraction, speed of AV conduction, and causes t
he release of renin in the kidneys ANS - Beta1
receptor subtype that causes dilation of arterioles in the heart, lungs, and skeletal muscles, bronchial di
lation, uterine relaxation, glycogenolysis, and enhanced contraction of skeletal muscles ANS - Beta2
receptor subtype that effects the kidney by dilating its vasculature ANS - Dopamine
alpha1, alpha2, beta1, beta2, and dopamine are all receptor subtypes ANS - adrenergic
medication used to treat non-obstructive urinary retention ANS - Bethanechol
medication that's investigational use is to treat gastroesophageal reflux ANS - Bethanechol
medication shouldn't be used with someone who has latent or active asthma, because it causes bronchi
al constriction ANS - Bethanechol
med that should be taken without food (to avoid nausea/vomiting), so administered 1 hour before mea
ls or 2 hours after meals ANS - Bethanechol
Pilocarpine acts by lowering intraocular pressure in the eyes which treats ANS - Glaucoma
a condition that causes DIFFICULTY SWALLOWING, ptosis, fatigue, and muscle weakmess ANS -
Myasthenia gravis
